BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, Inc. (NASDAQ:BIND) belongs to Healthcare sector. Its weekly performance is -2.68%. On last trading day company shares ended up $8.36. BIND Therapeutics, Inc. (NASDAQ:BIND) distance from 50-day simple moving average (SMA50) is -11.60%.
Bristol-Myers Squibb (NYSE:BMS) has announced it is no longer pursuing approval from the US Food and Drug Administration (FDA) for approval of the dual regiment of daclatasvir and asunaprevir for the treatment of patients with hepatitis C (HCV) genotype 1b. Bristol-Myers Squibb Company (NYSE:BMY) shares moved down -2.62% in last trading session and ended the day at $49.77. BMY Gross Margin is 73.30% and its return on assets is 7.60%. Bristol-Myers Squibb Company (NYSE:BMY) quarterly performance is 4.60%.
TransCanada is doing its part to ride the MLP wave. It has a New York Stock Exchange-traded entity, TC PipeLines LP (NYSE:TCP), that is gradually buying TransCanada’s U.S. assets for cash and distributing the profits to the MLP’s investors in a tax-advantaged manner. Wednesday’s TransCanada sale of its final 30 per cent interest in Bison Pipeline LLC for $215-million (U.S.) was widely seen as a move to assuage agitated investors, but analysts note there are still a number of assets to “drop down” to the MLP, and no explicit schedule to do so. On 07 October, TC PipeLines, LP (NYSE:TCP) shares advanced 0.25% and was closed at $67.25. TCP EPS growth in last 5 year was -4.70%. TC PipeLines, LP (NYSE:TCP) year to date (YTD) performance is 43.45%.
New England recently learned about a huge rate increase that will soon have some people paying nearly 40 percent more for electricity. Part of what’s driving the increase is the escalating cost of bringing natural gas into the region. Martin Cohn and a few others from reactor-owner Entergy Corporation (NYSE:ETR) lead a tour through several checkpoints guarded by security officers. Besides metal detectors, there are also machines that test for explosive residue and check visitors’ hand dimensions against stored information. A white tank-like vehicle with mounted cameras patrols the area between checkpoints. Entergy Corporation (NYSE:ETR) ended the last trading day at $77.81. Company weekly volatility is calculated as 1.68% and price to cash ratio as 21.50. Entergy Corporation (NYSE:ETR) showed a weekly performance of 0.62%.
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) EVP Donald G. Payan unloaded 20,000 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $2.56, for a total value of $51,200.00. Following the completion of the transaction, the executive vice president now directly owns 68,334 shares of the company’s stock, valued at approximately $174,935. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares moved down -5.26% in last trading session and ended the day at $1.80. RIG’s return on assets is -41.50%. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) quarterly performance is -47.37%.